News & Updates
Filter by Specialty:
Ixazomib regimens disappoint in older patients with multiple myeloma
06 Jan 2022
Induction with ixazomib-based regimens appear to be insufficient for older patients newly diagnosed multiple myeloma who are ineligible for transplantation, achieving an unsatisfactory progression-free survival (PFS) rate, reports a recent study.
Ixazomib regimens disappoint in older patients with multiple myeloma
06 Jan 2022Robotic-assisted radical cystectomy for bladder cancer: Intracorporeal urinary diversion of benefit
06 Jan 2022
byChristina Lau
Intracorporeal urinary diversion (ICUD) is associated with similar postoperative complication rates, reduced blood loss and shorter hospitalization vs extracorporeal urinary diversion (ECUD) in patients undergoing robotic-assisted radical cystectomy (RARC) for localized bladder cancer, data from the Asian RARC Consortium registry have shown.